<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> active Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> occurs sporadically in a small fraction of individuals infected with EBV </plain></SENT>
<SENT sid="1" pm="."><plain>A clear definition of the disease and an unambiguous diagnostic test are still lacking </plain></SENT>
<SENT sid="2" pm="."><plain>In an attempt to identify a serologic marker to facilitate the diagnosis, immunoblot and radioimmunoprecipitation assay (RIPA) were compared with standard immunofluorescence on 39 available sera </plain></SENT>
<SENT sid="3" pm="."><plain>Results by RIPA revealed that antibodies to a 120 kDa <z:mp ids='MP_0001799'>viral</z:mp> protein correlated with the presence of <z:hpo ids='HP_0011010'>chronic</z:hpo> active <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e>; these antibodies were not detected in sera from other EBV-seropositive individuals, with the exception of one of two patients with <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Also, RIPA was the most sensitive technique for detecting EBV antibodies in sera weakly or doubtfully positive for antibody to EB <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen by indirect immunofluorescence </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these sera had antibodies to the 150 kDa protein, also known as p160, the major <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen </plain></SENT>
</text></document>